UnitedHealth Group Incorporated (UNH) Earnings Call Transcripts

50 earnings calls from January 2020 to October 13, 2026

NYSE US Health Care Health Care Providers and Services

UnitedHealth Group Incorporated's Latest Earnings Call - Q3 FY2026

In the third quarter of 2026, UnitedHealth Group reported revenue of $113 billion and adjusted earnings per share (EPS) of $4.69, significantly up from $2.92 a year ago. The company reaffirmed its full-year adjusted EPS guidance of at least $20.50, reflecting a positive outlook for 2027 with a long-term growth target of 13% to 16%. Management emphasized ongoing improvements in operational execution across its segments, particularly in Medicare and Medicaid, while addressing rising healthcare costs and regulatory challenges.

Reported metrics

MetricValueContext
Revenue $113 billion (beat) vs $110 billion est, +8% YoY
Adjusted EPS $4.69 (beat) vs $3.90 est, +61% YoY
Medical Care Ratio 88.4% (positive) vs 89.9% last year
Medicare Advantage Savings $4,000 (positive) average savings for beneficiaries vs original Medicare
Debt to Capital Ratio 41.7% (positive) vs 42% last quarter
Stock Repurchase $5 billion (positive) through Q3 2026

Guidance from management

Management maintained its full-year adjusted EPS guidance of at least $20.50 and expressed confidence in achieving long-term growth targets of 13% to 16% in 2027 and beyond.

What management said

Lance, this is Tim. I'm going to turn it over to Brandon Davis, who is our new CEO of our Commercial business for some insights into the commercial selling season and our pricing posture there.
— Timothy Noel, Q3 FY2026 earnings call
Maybe just 2 quick other notes on biosimilar because you asked about that, we're seeing robust uptake across our clients, lowest net cost. Our Optum specialty distribution, if we stood up is functioning well. Last thing I'll call out across Christ and John's team. really great collaboration between the Optum Health clinicians and the pharmacies to make sure we're providing that integrated care experience for the pati...
— Timothy Noel, Q3 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns about the ongoing high costs in specialty pharmacy and the impact of regulatory changes on margins. There were also questions regarding the stability of Medicaid funding and how it might affect future performance.

Main topics on the call

Read the full UnitedHealth Group Incorporated transcript (Q3 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About UnitedHealth Group Incorporated

UnitedHealth Group Incorporated (UNH) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 50 calls on record spanning January 15, 2020 to October 13, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 50 UnitedHealth Group Incorporated earnings call transcripts on record, spanning January 15, 2020 to October 13, 2026. Based on this history, UnitedHealth Group Incorporated reports quarterly. The most recent call on file is dated October 13, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
UNH
Exchange
NYSE
Country
US
Sector
Health Care
Industry
Health Care Providers and Services
Calls on record
50
First call
January 15, 2020
Most recent
October 13, 2026
Reporting cadence
quarterly
Quarter Date
Q3 FY2026 Oct 13, 2026 Read transcript →
Company Conference Presentations Sep 9, 2026 Read transcript →
Q2 FY2026 Jul 16, 2026 Read transcript →
Company Conference Presentations May 12, 2026 Read transcript →
Q1 FY2026 Apr 21, 2026 Read transcript →
Company Conference Presentations Mar 10, 2026 Read transcript →
Earnings Calls Jan 27, 2026 Read transcript →
Company Conference Presentations Nov 10, 2025 Read transcript →
Q2 FY2025 Jul 29, 2025 Read transcript →
Special Calls May 13, 2025 Read transcript →
Q1 FY2025 Apr 17, 2025 Read transcript →
Q4 FY2024 Jan 16, 2025 Read transcript →
Analyst/Investor Day Dec 4, 2024 Read transcript →
Q3 FY2024 Oct 15, 2024 Read transcript →
Q2 FY2024 Jul 16, 2024 Read transcript →
Company Conference Presentations May 29, 2024 Read transcript →
Company Conference Presentations May 14, 2024 Read transcript →
Q1 FY2024 Apr 16, 2024 Read transcript →
Q4 FY2023 Jan 12, 2024 Read transcript →
Analyst/Investor Day Nov 29, 2023 Read transcript →
Q3 FY2023 Oct 13, 2023 Read transcript →
Q2 FY2023 Jul 14, 2023 Read transcript →
Company Conference Presentations Jun 13, 2023 Read transcript →
Company Conference Presentations Jun 1, 2023 Read transcript →
Q1 FY2023 Apr 14, 2023 Read transcript →
Q4 FY2022 Jan 13, 2023 Read transcript →
Analyst/Investor Day Nov 29, 2022 Read transcript →
Q3 FY2022 Oct 14, 2022 Read transcript →
Company Conference Presentations Sep 13, 2022 Read transcript →
Q2 FY2022 Jul 15, 2022 Read transcript →
Company Conference Presentations May 10, 2022 Read transcript →
Q1 FY2022 Apr 14, 2022 Read transcript →
Q4 FY2021 Jan 19, 2022 Read transcript →
Analyst/Investor Day Nov 30, 2021 Read transcript →
Q3 FY2021 Oct 14, 2021 Read transcript →
Q2 FY2021 Jul 15, 2021 Read transcript →
Shareholder/Analyst Calls Jun 7, 2021 Read transcript →
Company Conference Presentations Jun 2, 2021 Read transcript →
Company Conference Presentations May 11, 2021 Read transcript →
Q1 FY2021 Apr 15, 2021 Read transcript →
Company Conference Presentations Mar 10, 2021 Read transcript →
Q4 FY2020 Jan 20, 2021 Read transcript →
Special Calls Dec 1, 2020 Read transcript →
Q3 FY2020 Oct 14, 2020 Read transcript →
Q2 FY2020 Jul 15, 2020 Read transcript →
Shareholder/Analyst Calls Jun 1, 2020 Read transcript →
Q1 FY2020 Apr 15, 2020 Read transcript →
Company Conference Presentations Mar 12, 2020 Read transcript →
Company Conference Presentations Jan 15, 2020 Read transcript →
Q4 FY2019 Jan 15, 2020 Read transcript →